about
Mitochondrial functional impairment in response to environmental toxins in the cardiorenal metabolic syndromeOvernutrition, mTOR signaling, and cardiovascular diseases.Estrogen and mitochondria function in cardiorenal metabolic syndrome.Clinician's guide to the updated ABCs of cardiovascular disease prevention.Evolution of pharmacological obesity treatments: focus on adverse side-effect profiles.
P2860
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Therapy of obese patients with cardiovascular disease.
@en
type
label
Therapy of obese patients with cardiovascular disease.
@en
prefLabel
Therapy of obese patients with cardiovascular disease.
@en
P2093
P2860
P1476
Therapy of obese patients with cardiovascular disease.
@en
P2093
Adam Whaley-Connell
Ankur Jindal
James R Sowers
Stephen Brietzke
P2860
P304
P356
10.1016/J.COPH.2012.12.006
P577
2013-01-17T00:00:00Z